Benzoxazoline and benzimidazoline derivatives as novel aldose reductase inhibitors, part 2: Lead optimization

Medicinal Chemistry Research

Volumn 9, Issue 7-8, 1999, Pages 631-642

  Nakao, Kazuya ^a   Asao, Masaaki ^a   Shirai, Hiroki ^a   Saito, Kiyoshi ^a   Moriya, Tamon ^a   Iwata, Hiroshi ^a   Matsumoto, Mamoru ^a   Matsuoka, Yuzo ^a   Shimizu, Ryo ^a  

^a MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSE REDUCTASE INHIBITOR; IMIDAZOLINE DERIVATIVE; OXAZOLINE DERIVATIVE;

ARTICLE; CRYSTAL STRUCTURE; DERIVATIZATION; DRUG SYNTHESIS; ENZYME INHIBITION; HYDROPHOBICITY; MOLECULAR INTERACTION; QUANTITATIVE STRUCTURE ACTIVITY RELATION; X RAY CRYSTALLOGRAPHY;

EID: 0033367146     PISSN: 10542523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. 1. Nakao, K.; Asao, M.; Shirai, H.; Saito, K.; Moriya, T.; Iwata, H; Matsumoto, M.; Matsuoka, Y.; Shimizu, R. Benzoxazoline and Benzimidazoline Derivatives as Novel Aldose Reductase Inhibitors, Part 1: Lead Evolution. Med. Chem. Res. The previous paper in this issue.
2. 2. Cramer III, R. D.; Pattersn, D. E.; Bunce, J. D. Comparative Molecular Field Analysis (CoMFA). 1. Effect of Shape on Binding of Steroids to Carrier Proteins. J. Am. Chem. Soc. 1988, 110, 5959-5967.
3. 3. Yamagishi, M.; Yamada, Y.; Ozaki, K.; Asao, M.; Shimizu, R.; Suzuki, M.; Matsumoto, M.; Matsuoka, Y.; Matsumoto, K. Biological Activities and Quantitative Structure-Activity Relationships of Spiro[imidazolidine-4, 4'(1'H)-quinazoline]-2, 2', 5(3'H)-triones as Aldose Reductase Inhibitors. J. Med. Chem. 1992, 35, 2085-2094.
4. 4. Nakao, K.; Asao, M.; Shirai, H.; Shimizu, R. 3D-Pharmacophore Analyses of Aldose Reductase Inhibitory Spiroquinazolinones. Drug Design and Discovery 1999, 16, 155-163.
5. 5. Stewart, J. J. P. MOPAC: A Semiempirical Molecular Orbital Program. J. Comput.-Aided Mol. Design 1990, 4, 1-105.
6. 6. Dewar, M. J. S.; Zoebisch, E. G.; Healy, E. F.; Stewart, J. J. P. AM1: A New General Purpose Quantum Mechanical Molecular Model. J. Am. Chem. Soc. 1985, 107, 3902-3909.
7. 7. Dewar, M. J. S.; Thiel, W. Ground States of Molecules. 38. The MNDO method. Approximations and Parameters. J. Am. Chem. Soc. 1977, 99, 4899-4907.
8. 8. Urzhumtsev, A.; Tete-Favier, F.; Mitschler, A.; Barbanton, J.; Barth, P.; Urzhumtseva, L.; Biellmann, J.-F.; Podjamy, A. D.; Moras, D. A 'Specificity' Pocket Inferred from the Crystal Structures of the Complexes of Aldose Reductase with the Pharmaceutically Important Inhibitors Tolrestat and Sorbinil. Structure, 1997, 5, 601-612.
9. 9. Lee, Y. S.; Chen, Z.; Kador, P. F. Molecular Modeling Studies of the Binding Modes of Aldose Reductase Inhibitors at the Active Site of Human Aldose Reductase. Bioorg. Med. Chem. 1998, 6, 1811-1819.
10. 10. SYBYL molecular modeling software. Tripos, Inc. 1699, S. Hanley Road, St. Louis, MO 63144-2913, U.S.A.
11. 11. Kellogg, G. E.; Semus, S.; Abraham, D. J. HINT: A New Method of Empirical Hydrophobic Field Calculation for CoMFA. J. Comput.-Aided Mol. Design 1991, 5, 545-552.
12. 12. EduSoft, LC. Ashland, VA 23005, U. S. A.